Variant report

Variant	rs10896167
Chromosome Location	chr11:67065889-67065890
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr11:67064219..67065904-chr11:67074110..67076020,2	K562	blood:
2	chr11:67054455..67063331-chr11:67064649..67075279,24	K562	blood:
3	chr11:67041964..67046049-chr11:67065840..67069328,4	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SSH3-2	chr11:67065362-67067092	NONHSAT022390

Variant related genes	Relation type
ENSG00000172830	Chromatin interaction
ENSG00000172932	Chromatin interaction
ENSG00000173020	Chromatin interaction

Extended variants
information (count: 70 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:57)

rs_ID	r²[population]
rs10896154	0.88[CEU][hapmap];0.92[CHB][hapmap];0.86[YRI][hapmap]
rs10896164	0.82[AMR][1000 genomes]
rs10896168	0.95[AFR][1000 genomes];0.95[AMR][1000 genomes];0.98[ASN][1000 genomes]
rs10896169	0.95[AFR][1000 genomes];0.98[AMR][1000 genomes];0.96[ASN][1000 genomes]
rs11227756	0.92[ASW][hapmap];1.00[CHB][hapmap];0.97[CHD][hapmap];0.85[JPT][hapmap];0.93[LWK][hapmap];1.00[MEX][hapmap];0.85[MKK][hapmap];1.00[TSI][hapmap];0.93[YRI][hapmap]
rs11227788	0.85[ASN][1000 genomes]
rs11601700	0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs11608094	0.92[AFR][1000 genomes];0.91[AMR][1000 genomes];0.85[ASN][1000 genomes]
rs12288107	0.92[ASW][hapmap];0.85[CHD][hapmap];0.83[GIH][hapmap];0.86[JPT][hapmap];0.83[LWK][hapmap];1.00[MEX][hapmap];0.90[MKK][hapmap]
rs12290164	0.92[ASW][hapmap];0.85[CHD][hapmap];0.83[GIH][hapmap];0.93[JPT][hapmap];0.83[LWK][hapmap];1.00[MEX][hapmap];0.90[MKK][hapmap]
rs12788752	1.00[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.86[LWK][hapmap];0.95[MEX][hapmap];0.94[MKK][hapmap];0.93[YRI][hapmap];0.86[AFR][1000 genomes];0.90[AMR][1000 genomes]
rs12791853	0.83[GIH][hapmap]
rs1540135	0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs1558256	0.92[ASW][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];0.93[JPT][hapmap];0.93[LWK][hapmap];1.00[MEX][hapmap];0.84[MKK][hapmap];0.85[ASN][1000 genomes]
rs1638566	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.96[LWK][hapmap];1.00[MEX][hapmap];0.97[MKK][hapmap];1.00[TSI][hapmap];0.93[YRI][hapmap];0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs1638567	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.96[LWK][hapmap];1.00[MEX][hapmap];0.97[MKK][hapmap];1.00[TSI][hapmap];0.93[YRI][hapmap];0.87[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs1638571	1.00[ASW][hapmap];1.00[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.93[LWK][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.86[YRI][hapmap];0.83[AFR][1000 genomes];0.89[AMR][1000 genomes];0.83[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs1638574	0.91[AFR][1000 genomes];0.91[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs1638586	0.92[ASW][hapmap];0.83[GIH][hapmap];0.83[LWK][hapmap];0.86[MEX][hapmap];0.90[MKK][hapmap];0.85[YRI][hapmap]
rs1790733	0.92[ASW][hapmap];0.85[CHD][hapmap];0.83[GIH][hapmap];0.86[JPT][hapmap];0.93[LWK][hapmap];1.00[MEX][hapmap];0.90[MKK][hapmap]
rs1790740	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.96[LWK][hapmap];1.00[MEX][hapmap];0.96[MKK][hapmap];1.00[TSI][hapmap];0.93[YRI][hapmap];0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs1790747	0.92[ASW][hapmap];0.81[CHD][hapmap];0.83[GIH][hapmap];0.86[JPT][hapmap];1.00[MEX][hapmap];0.91[MKK][hapmap]
rs2066496	0.88[CEU][hapmap];0.86[CHD][hapmap];0.83[GIH][hapmap];0.92[JPT][hapmap]
rs2071007	0.92[ASW][hapmap];1.00[CHB][hapmap];0.97[CHD][hapmap];0.96[LWK][hapmap];1.00[MEX][hapmap];0.85[MKK][hapmap];1.00[TSI][hapmap];0.81[YRI][hapmap];0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];0.87[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs2256154	0.95[CHD][hapmap];0.93[JPT][hapmap];0.86[ASN][1000 genomes]
rs2286620	0.88[CEU][hapmap];0.86[CHD][hapmap];0.83[GIH][hapmap];0.84[JPT][hapmap]
rs2298815	0.83[GIH][hapmap]
rs2429460	0.95[AFR][1000 genomes];0.89[AMR][1000 genomes];0.91[ASN][1000 genomes]
rs2429462	0.92[AFR][1000 genomes];0.94[AMR][1000 genomes];0.93[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2514256	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.93[LWK][hapmap];0.95[MEX][hapmap];0.90[MKK][hapmap];0.82[TSI][hapmap];0.85[YRI][hapmap];0.86[ASN][1000 genomes]
rs2514258	0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.93[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs3737460	0.83[GIH][hapmap]
rs3758943	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.93[YRI][hapmap]
rs3781941	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.86[LWK][hapmap];1.00[MEX][hapmap];0.94[MKK][hapmap];1.00[TSI][hapmap];0.93[YRI][hapmap];0.86[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs3781942	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];1.00[JPT][hapmap];0.93[LWK][hapmap];1.00[MEX][hapmap];0.94[MKK][hapmap];1.00[TSI][hapmap];0.93[YRI][hapmap];0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs3781943	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.96[LWK][hapmap];1.00[MEX][hapmap];0.97[MKK][hapmap];0.90[TSI][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs3909168	0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs3927807	1.00[ASW][hapmap];1.00[CEU][hapmap];0.92[CHB][hapmap];0.85[JPT][hapmap];0.92[LWK][hapmap];0.81[MKK][hapmap];0.85[YRI][hapmap];0.86[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs4024520	0.84[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[ASN][1000 genomes]
rs4244819	0.92[ASW][hapmap];1.00[CEU][hapmap];0.92[CHB][hapmap];0.97[CHD][hapmap];0.85[GIH][hapmap];0.85[JPT][hapmap];0.96[LWK][hapmap];1.00[MEX][hapmap];0.85[MKK][hapmap];1.00[TSI][hapmap];0.86[YRI][hapmap]
rs4255546	1.00[CEU][hapmap];1.00[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];0.92[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4375446	0.92[ASW][hapmap];1.00[CEU][hapmap];0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];0.85[JPT][hapmap];0.96[LWK][hapmap];1.00[MEX][hapmap];0.85[MKK][hapmap];1.00[TSI][hapmap];0.86[YRI][hapmap]
rs4478996	0.92[ASW][hapmap];1.00[CEU][hapmap];0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];0.85[JPT][hapmap];0.96[LWK][hapmap];1.00[MEX][hapmap];0.85[MKK][hapmap];0.90[TSI][hapmap];0.86[YRI][hapmap]
rs4503557	0.86[AFR][1000 genomes];0.81[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs4542419	0.92[ASW][hapmap];0.84[CHB][hapmap];0.97[CHD][hapmap];0.85[JPT][hapmap];0.89[LWK][hapmap];0.85[MKK][hapmap];1.00[TSI][hapmap];0.86[YRI][hapmap];0.81[EUR][1000 genomes]
rs4930192	1.00[CEU][hapmap];0.86[CHD][hapmap];1.00[GIH][hapmap];0.92[JPT][hapmap];0.90[TSI][hapmap];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs4930197	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.86[LWK][hapmap];1.00[MEX][hapmap];0.94[MKK][hapmap];1.00[TSI][hapmap];0.93[YRI][hapmap];0.83[AFR][1000 genomes];0.91[AMR][1000 genomes];0.88[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs4930418	1.00[CEU][hapmap];0.84[CHB][hapmap];0.86[CHD][hapmap];1.00[GIH][hapmap];0.92[JPT][hapmap];0.90[TSI][hapmap];0.91[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs56337023	0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs6591239	0.81[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs660960	0.92[CHB][hapmap];0.85[JPT][hapmap];0.86[YRI][hapmap];0.81[EUR][1000 genomes]
rs674499	0.92[ASW][hapmap];0.84[CHB][hapmap];0.92[CHD][hapmap];1.00[GIH][hapmap];0.85[JPT][hapmap];0.88[LWK][hapmap];1.00[MEX][hapmap];0.85[MKK][hapmap];1.00[TSI][hapmap];0.86[YRI][hapmap];0.90[EUR][1000 genomes]
rs7106352	0.92[AFR][1000 genomes];0.91[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs7113390	0.81[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs7480390	0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[JPT][hapmap];0.86[ASN][1000 genomes]
rs872109	0.86[ASN][1000 genomes]
rs872110	0.92[ASW][hapmap];0.88[CEU][hapmap];0.92[CHB][hapmap];1.00[CHD][hapmap];0.83[GIH][hapmap];0.93[JPT][hapmap];0.83[LWK][hapmap];1.00[MEX][hapmap];0.90[MKK][hapmap];0.82[TSI][hapmap];0.85[YRI][hapmap];0.85[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:13 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv531397	chr11:66653381-67465721	Active TSS Enhancers Strong transcription Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	271 gene(s)	inside rSNPs	diseases
2	nsv933183	chr11:67008447-67160993	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	88 gene(s)	inside rSNPs	diseases
3	nsv897796	chr11:67021518-67186000	Weak transcription Strong transcription Active TSS Flanking Active TSS Enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
4	nsv897797	chr11:67023040-67293234	Flanking Active TSS Strong transcription Enhancers Active TSS Weak transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	206 gene(s)	inside rSNPs	diseases
5	nsv897799	chr11:67024534-67072623	Flanking Active TSS Bivalent Enhancer Enhancers Active TSS Weak transcription Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	41 gene(s)	inside rSNPs	diseases
6	nsv897800	chr11:67024534-67086298	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	50 gene(s)	inside rSNPs	diseases
7	nsv1043037	chr11:67027193-67357425	Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Genic enhancers Active TSS ZNF genes & repeats Weak transcription Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	213 gene(s)	inside rSNPs	diseases
8	nsv468603	chr11:67033076-67164495	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	85 gene(s)	inside rSNPs	diseases
9	nsv555253	chr11:67033076-67164495	Weak transcription Strong transcription Flanking Active TSS Genic enhancers Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	85 gene(s)	inside rSNPs	diseases
10	nsv897801	chr11:67033076-67432479	Bivalent Enhancer Enhancers Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	236 gene(s)	inside rSNPs	diseases
11	nsv897802	chr11:67051245-67075024	Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
12	nsv1047890	chr11:67058231-67184436	Flanking Active TSS Enhancers Strong transcription Genic enhancers Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	88 gene(s)	inside rSNPs	diseases
13	nsv1048230	chr11:67058231-67252397	Active TSS Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	146 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:124 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:67057600-67067000	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr11:67057600-67069200	Weak transcription	Psoas Muscle	Psoas
3	chr11:67058600-67066600	Weak transcription	HSMMtube	muscle
4	chr11:67058600-67069200	Weak transcription	Fetal Heart	heart
5	chr11:67059800-67066200	Weak transcription	H1 Cell Line	embryonic stem cell
6	chr11:67059800-67066200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
7	chr11:67059800-67066200	Weak transcription	Rectal Smooth Muscle	rectum
8	chr11:67059800-67066400	Weak transcription	Gastric	stomach
9	chr11:67059800-67066800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr11:67059800-67067800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
11	chr11:67060000-67066200	Weak transcription	Colonic Mucosa	Colon
12	chr11:67060000-67066200	Weak transcription	Right Ventricle	heart
13	chr11:67060000-67066400	Weak transcription	Lung	lung
14	chr11:67060000-67066400	Weak transcription	Skeletal Muscle Male	skeletal muscle
15	chr11:67060000-67066600	Weak transcription	Aorta	Aorta
16	chr11:67060000-67066800	Weak transcription	Pancreas	Pancrea
17	chr11:67060000-67067000	Strong transcription	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr11:67060000-67068000	Strong transcription	Fetal Muscle Trunk	muscle
19	chr11:67060000-67069400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr11:67060000-67069600	Strong transcription	Primary Natural Killer cells fromperipheralblood	blood
21	chr11:67060200-67066200	Weak transcription	Brain Angular Gyrus	brain
22	chr11:67060200-67066400	Weak transcription	Brain Cingulate Gyrus	brain
23	chr11:67060800-67066000	Weak transcription	Brain Hippocampus Middle	brain
24	chr11:67060800-67066200	Weak transcription	Colon Smooth Muscle	Colon
25	chr11:67061000-67066800	Weak transcription	Stomach Mucosa	stomach
26	chr11:67061200-67066600	Weak transcription	Placenta Amnion	Placenta Amnion
27	chr11:67061200-67069000	Strong transcription	Osteobl	bone
28	chr11:67061200-67069800	Weak transcription	Small Intestine	intestine
29	chr11:67061400-67069000	Strong transcription	IMR90 fetal lung fibroblasts Cell Line	lung
30	chr11:67062000-67066200	Strong transcription	Monocytes-CD14+_RO01746	blood
31	chr11:67062000-67069000	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
32	chr11:67062200-67070400	Strong transcription	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr11:67063200-67066800	Weak transcription	Left Ventricle	heart
34	chr11:67063200-67066800	Weak transcription	Ovary	ovary
35	chr11:67063200-67067800	Strong transcription	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr11:67063600-67067000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
37	chr11:67063600-67067000	Strong transcription	HSMM	muscle
38	chr11:67063600-67069200	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr11:67063600-67069200	Weak transcription	Fetal Brain Male	brain
40	chr11:67063600-67069400	Strong transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr11:67063800-67066000	Weak transcription	Duodenum Smooth Muscle	Duodenum
42	chr11:67063800-67066600	Weak transcription	Duodenum Mucosa	Duodenum
43	chr11:67063800-67066800	Weak transcription	Liver	Liver
44	chr11:67063800-67068000	Strong transcription	Fetal Muscle Leg	muscle
45	chr11:67063800-67069400	Strong transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr11:67063800-67069800	Weak transcription	Pancreatic Islets	Pancreatic Islet
47	chr11:67063800-67070000	Strong transcription	Primary mononuclear cells fromperipheralblood	Blood
48	chr11:67063800-67070000	Weak transcription	Fetal Kidney	kidney
49	chr11:67063800-67070400	Strong transcription	Dnd41	blood
50	chr11:67064000-67066200	Strong transcription	Primary T regulatory cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links